Longshenrongfa Pharmaceutical Industry
30053413.682.32% ( +0.31 )
Longshenrongfa Pharmaceutical Industry (300534)
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health produc...
- Open
- 13.03
- High
- 14.50
- Low
- 11.90
- Prev. Close
- 13.37
- Volume
- 462.08K
- Turnover
- 618.10M
- Avg Price
- 13.38
- Bid/Ask Ratio
- 26.44%
- Amplitude
- 19.45%
- 52wk High
- 15.62
- Volume Ratio
- 6.09
- Turnover Ratio
- 15.23%
News
- Zhitong · Oct 24, 2025 at 04:34 AM
Longshenrongfa Pharmaceutical Industry released its performance for the first three quarters, with a net profit attributable to the parent company of 27.0294 million yuan, an increase of 8.11%
- Zhitong · Oct 24, 2025 at 03:28 AM
Longshenrongfa Pharmaceutical Industry: Net profit loss of 926,700 yuan in the third quarter
- Zhitong · Sep 26, 2025 at 03:45 AM
Longshenrongfa Pharmaceutical Industry: Zhao Zhengcai resigns as Chief Financial Officer, Xiao Rong takes over
- Zhitong · Sep 25, 2025 at 03:36 AM
Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Manufacturing License"
- Zhitong · Sep 19, 2025 at 03:26 AM
Longshenrongfa Pharmaceutical Industry: Tongmai Oral Liquid Approved for Market Sale
- Zhitong · Sep 15, 2025 at 03:21 AM
Gansu Longshenrongfa Pharmaceutical Industry announced the implementation of the 2025 semi-annual dividend distribution
